Penumbra Inc (STU:0P8)
€ 212.2 2.5 (1.19%) Market Cap: 8.20 Bil Enterprise Value: 8.14 Bil PE Ratio: 266.87 PB Ratio: 7.97 GF Score: 87/100

Penumbra Inc at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 01:00PM GMT
Release Date Price: €224 (-1.75%)
William John Plovanic
Canaccord Genuity Corp., Research Division - MD of Life Science Research

Great. Good morning. Thank you for joining us at Canaccord's 43rd Annual Global Growth Conference. I am Bill Plovanic, one of the Canaccord senior medical device analysts. We're excited to host Penumbra. And with us today is Jason Mills, EVP of Strategy. Thanks for joining us today, Jason.

Jason Richard Mills
Penumbra, Inc. - EVP of Strategy

Thank you.

William John Plovanic
Canaccord Genuity Corp., Research Division - MD of Life Science Research

And just a reminder, the format today is a brief overview presentation followed by a fireside -- the format today is a brief overview presentation followed by a fireside chat Q&A session. And with that, I'd like to hand it over to Jason.

Jason Richard Mills
Penumbra, Inc. - EVP of Strategy

Thanks, Bill. I think I'm mic-ed up, so maybe I'll be able to hear without these microphones. Thank you very much. My name is Jason Mills. As

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot